Heart failure patients may get a new diuretic boost
NCT ID NCT06285760
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether adding a drug called acetazolamide (used for glaucoma) to standard heart failure treatment helps people with acute heart failure pass more urine and salt. Researchers will measure urine output over 24 hours in 64 hospitalized adults who still have fluid buildup despite taking furosemide and SGLT2 inhibitors. The goal is to see if this combination works better at reducing congestion.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Julia González González
RECRUITINGMadrid, 28222, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital nurse companion: could an app ease the burden of chronic illness?
- Could continuing a common heart drug before surgery save lives?
- Poles apart? nordic walking may outpace standard rehab for heart failure
- Could a gentler tug on the Heart's reins spark recovery?
- Can slow breathing soothe a failing heart?
- Can shedding pounds reboot the Heart's exercise engine?